Not Tagged
Chemomab Therapeutics
[]
$cmmb is up 14.45% as chemomab's anti-ccl24 antibody, cm-101, shows potential clinical utility in breaking the fibro-inflammatory vicious cycle in ssc and other fibrotic diseases. #chemomabtherapeutics 
Stock Market Trader - Follow your own opinions